Main > RHEUMATOLOGY > Rheumatoid Arthritis > Treatment > Co.: KR. S. BioSimilar InflixiMAb

---

Co.: KR. S. BioSimilar InflixiMAb's subsections
Approved in EU; KR & USA
Company
Marketing in USA By:
TradeMark (EU, KR)
TradeMark (USA)
UpDate: 2017. 04.24.

Co.: KR. S. BioSimilar InflixiMAb's products
This section has no products